Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$42.66 - $50.04 $4.14 Million - $4.86 Million
-97,078 Reduced 59.5%
66,090 $2.85 Million
Q4 2023

Feb 14, 2024

BUY
$28.7 - $46.46 $3.13 Million - $5.07 Million
109,172 Added 202.19%
163,168 $7.52 Million
Q3 2023

Nov 13, 2023

SELL
$34.16 - $39.73 $1.56 Million - $1.82 Million
-45,760 Reduced 45.87%
53,996 $1.84 Million
Q2 2023

Aug 14, 2023

BUY
$34.84 - $43.54 $108,456 - $135,540
3,113 Added 3.22%
99,756 $3.84 Million
Q1 2023

May 15, 2023

SELL
$33.46 - $40.35 $5.25 Million - $6.34 Million
-157,012 Reduced 61.9%
96,643 $3.46 Million
Q4 2022

Feb 14, 2023

BUY
$33.06 - $39.43 $253,338 - $302,152
7,663 Added 3.12%
253,655 $10 Million
Q3 2022

Oct 28, 2022

BUY
$30.79 - $39.82 $411,415 - $532,074
13,362 Added 5.74%
245,992 $8.88 Million
Q2 2022

Jul 25, 2022

BUY
$25.44 - $35.16 $3.35 Million - $4.63 Million
131,549 Added 130.14%
232,630 $7.08 Million
Q1 2022

May 13, 2022

BUY
$25.09 - $33.13 $27,122 - $35,813
1,081 Added 1.08%
101,081 $1.43 Million
Q4 2021

Feb 14, 2022

BUY
$15.6 - $35.4 $1.26 Million - $2.85 Million
80,568 Added 414.62%
100,000 $3.12 Million
Q3 2021

Nov 15, 2021

BUY
$14.86 - $19.45 $288,759 - $377,952
19,432 New
19,432 $297,000

Others Institutions Holding XENE

About Xenon Pharmaceuticals Inc.


  • Ticker XENE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,263,500
  • Market Cap $2.39B
  • Description
  • Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...
More about XENE
Track This Portfolio

Track Silverarc Capital Management, LLC Portfolio

Follow Silverarc Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Silverarc Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Silverarc Capital Management, LLC with notifications on news.